Criteria to rationalize population screening to control oral cancer

Oral Oncology

Volumn 41, Issue 1, 2005, Pages 11-16

  Lavelle, Christopher L B ^a   Scully, Crispian ^b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Aneuploidy; DNA content; Oral carcinoma; Oral precancer; Risk markers

Indexed keywords

APOPTOSIS; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CARCINOGENESIS; CARDIOLOGY; CLINICAL TRIAL; GENE MUTATION; GENE THERAPY; GENETIC HETEROGENEITY; HEALTH CARE; HEALTH EDUCATION; HUMAN; LABORATORY DIAGNOSIS; MOLECULAR BIOLOGY; MOUTH CANCER; OUTCOMES RESEARCH; PLOIDY; POPULATION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; VALIDATION PROCESS;

CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; DNA, NEOPLASM; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MASS SCREENING; MOUTH NEOPLASMS; PLOIDIES;

EID: 10644256361     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2004.04.009     Document Type: Review

References (63)

1. Black W.C. Overdiagnosis. An underrecognized cause of confusion and harm in cancer screening. J. Natl. Cancer Inst. 92:2000;1280-1282
2. Baxter N. Canadian Task Force on Preventive Health Care. Preventive health care, 2001 update: should women be routinely taught breast self-examination to screen for breast cancer? CMAJ. 164:2001;1837-1846
3. Olsen O., Gotzsche P.C. Cochrane review on screening for breast cancer with mammography. Lancet. 358:2001;1340-1342
4. Woolf S.H. The accuracy and effectiveness of routine population screening with mammography, prostate-specific antigen, and prenatal ultrasound: a review of published scientific evidence. Int. J. Technol. Assess. Health Care. 17:2001;275-304
5. Kujan O., Glenny A.M., Duxbury A.J., Thakker N., Sloan P. Screening programmes for the early detection and prevention of oral cancer. The Cochrane library. vol. 1:2004;John Wiley & Sons, Ltd, Chichester, UK
6. Barratt A., Irwig L., Glasziou P., Cumming R.G., Raffle A., Hicks N., et al. Users' guides to the medical literature: XVII. How to use guidelines and recommendations about screening. Evidence-Based Medicine Working Group. JAMA. 281:1999;2029-2034
7. Rosenberg D., Cretin S. Use of meta-analysis to evaluate tolonium chloride in oral cancer screening. Oral Surg. Oral Med. Oral Pathol. 67:1989;621-627
8. Walker D.M., Boey G., McDonald L.A. The pathology of oral cancer. Pathology. 35:2003;376-383
9. Patton L.L. The effectiveness of community-based visual screening and utility of adjunctive diagnostic aids in the early detection of oral cancer. Oral Oncol. 39:2003;708-723
10. Swango P.A. Cancers of the oral cavity and pharynx in the United States: an epidemiologic overview. J. Public Health Dent. 56:1996;309-318
11. Rodstrom P.O., Jontell M., Mattsson U., Holmberg E. Cancer and oral lichen planus in a Swedish population. Oral Oncol. 40:2004;131-138
12. Epstein J.B., Wan L.S., Gorsky M., Zhang L. Oral lichen planus: progress in understanding its malignant potential and the implications for clinical management. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 96:2003;32-37
13. Sporn M.B. The war on cancer. Lancet. 347:1996;1377-1381
14. Llewellyn C.D., Johnson N.W., Warnakulasuriya K.A. Risk factors for squamous cell carcinoma of the oral cavity in young people - a comprehensive literature review. Oral Oncol. 37:2001;401-418
15. MacFarlane G.J., Sharp L., Porter S., Franceschi S. Trends in survival from cancers of the oral cavity and pharynx in Scotland: a clue as to why the disease is becoming more common? Br. J. Cancer. 73:1996;805-808
16. Newman A.N., Rice D.H., Ossoff R.H., Sisson G.A. Carcinoma of the tongue in persons younger than 30 years of age. Arch. Otolaryngol. 109:1983;302-304
17. Jaber M.A., Porter S.R., Scully C., Gilthorpe M.S., Bedi R. Role of alcohol in non-smokers and tobacco in non-drinkers in the aetiology of oral epithelial dysplasia. Int. J. Cancer. 77:1998;333-336
18. Jaber M.A., Porter S.R., Gilthorpe M.S., Bedi R., Scully C. Risk factors for oral epithelial dysplasia - the role of smoking and alcohol. Oral Oncol. 35:1999;151-156
19. Edwards P.A. Metastasis: the role of chance in malignancy. Nature. 419:2002;559-560
20. Vourlekis J.S., Szabo E. Predicting success in cancer prevention trials. J. Natl. Cancer Inst. 95:2003;178-179
21. Russo G., Zegar C., Giordano A. Advantages and limitations of microarray technology in human cancer. Oncogene. 22:2003;6497-6507
22. Lippman S.M., Hong W.K. Molecular markers of the risk of oral cancer. N. Engl. J. Med. 344:2001;1323-1326
23. Jones P.A., Baylin S.B. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3:2002;415-428
24. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell. 100:2000;57-70
25. Lee J.J., Hong W.K., Hittelman W.N., Mao L., Lotan R., Shin D.M., et al. Predicting cancer development in oral leukoplakia: ten years of translational research. Clin. Cancer Res. 6:2000;1702-1710
26. Vokes E.E., Weichselbaum R.R., Lippman S.M., Hong W.K. Head and neck cancer. N. Engl. J. Med. 328:1993;184-194
27. Mork J., Thoresen S., Faye-Lund H., Langmark F., Glattre E. Head and neck cancer in Norway. A study of the quality of the Cancer Registry of Norway's data on head and neck cancer for the period 1953-1991. APMIS. 103:1995;375-382
28. Nowak M.A., Komarova N.L., Sengupta A., Jallepalli P.V., Shih I.e.M., Vogelstein B., et al. The role of chromosomal instability in tumor initiation. Proc. Natl. Acad. Sci. USA. 99:2002;16226-16231
29. Mao L., Lee J.S., Fan Y.H., Ro J.Y., Batsakis J.G., Lippman S., et al. Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nat. Med. 2:1996;682-685
30. Braakhuis B.J., Tabor M.P., Kummer J.A., Leemans C.R., Brakenhoff R.H. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res. 63:2003;1727-1730
31. Girod S.C., Krueger G., Pape H.D. P53 and Ki67 expression in preneoplastic and neoplastic lesions of the oral mucosa. Int. J. Oral. Maxillofac. Surg. 22:1993;285-288
32. Wei Q., Cheng L., Amos C.I., Wang L.E., Guo Z., Hong W.K., Spitz M.R., et al. Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J. Natl. Cancer Inst. 92:2000;1764-1772
33. Lerman C., Berrettini W. Elucidating the role of genetic factors in smoking behavior and nicotine dependence. Am. J. Med. Genet. 118B:2003;48-54
34. Crabbe J.C. Alcohol and genetics: new models. Am. J. Med. Genet. 114:2002;969-974
35. Spitz M.R., Shi H., Yang F., Hudmon K.S., Jiang H., Chamberlain R.M., et al. Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. J. Natl. Cancer. Inst. 90:1998;358-363
36. Sabichi A.L., Demierre M.F., Hawk E.T., Lerman C.E., Lippman S.M. Frontiers in cancer prevention research. Cancer Res. 63:2003;5649-5655
37. Johnstone R.W., Ruefli A.A., Lowe S.W. Apoptosis: a link between cancer genetics and chemotherapy. Cell. 108:2002;153-164
38. Hong W.K., Endicott J., Itri L.M., Doos W., Batsakis J.G., Bell R., et al. 13-cis-retinoic acid in the treatment of oral leukoplakia. N. Engl. J. Med. 315:1986;1501-1505
39. Mao L., El-Naggar A.K., Papadimitrakopoulou V., Shin D.M., Shin H.C., Fan Y., et al. Phenotype and genotype of advanced premalignant head and neck lesions after chemopreventive therapy. J. Natl. Cancer Inst. 90:1998;1545-1551
40. Toth B.B., Martin J.W., Lippman S.M., Hong W.K. Chemoprevention as a form of cancer control. J. Am. Dent. Assoc. 124:1993;243-246
41. Papadimitrakopoulou V.A., Hong W.K., Lee J.S., Martin J.W., Lee J.J., Batsakis J.G., et al. Low-dose isotretinoin versus beta-carotene to prevent oral carcinogenesis: long-term follow-up. J. Natl. Cancer Inst. 89:1997;257-258
42. Rudin C.M., Cohen E.E., Papadimitrakopoulou V.A., Silverman S. Jr., Recant W., El-Naggar A.K., et al. An attenuated adenovirus, ONYX-015, as mouthwash therapy for premalignant oral dysplasia. J. Clin. Oncol. 21:2003;4546-4552
43. Parkin D.M., Bray F., Ferlay J., Pisani P. Estimating the world cancer burden: Globocan 2000. Int. J. Cancer. 94:2001;153-156
44. Pisani P., Parkin D.M., Bray F., Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int. J. Cancer. 83:1999;18-29
45. Campisi J. Cancer and ageing: rival demons? Nat. Rev. Cancer. 3:2003;339-349
46. Ames B.N., Gold L.S., Willett W.C. The causes and prevention of cancer. Proc. Natl. Acad. Sci. USA. 92:1995;5258-5265
47. Du M.Q., Isaccson P.G. Gastric MALT lymphoma: from aetiology to treatment. Lancet Oncol. 3:2002;97-104
48. Gillison M.L., Shah K.V. Chapter 9: role of mucosal human papillomavirus in nongenital cancers. J. Natl. Cancer Inst. Monogr. 31:2003;57-65
49. Wong M., Pagano J.S., Schiller J.T., Tevethian S.S., Raab-Traub N., Gruber J. New associations of human papillomavirus, simian virus 40, and Epstein-Barr virus with human cancer. J. Natl. Cancer Inst. 94:2002;1832-1836
50. Ritchie J.M., Smith E.M., Summersgill K.F., Hoffman H.T., Wang D., Klussmann J.P., et al. Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int. J. Cancer. 104:2003;336-344
51. Smith E.M., Hoffman H.T., Summersgill K.S., Kirchner H.L., Turek L.P., Haugen T.H. Human papillomavirus and risk of head and neck cancer. Laryngoscope. 108:1998;1098-1103
52. Schwartz S.M., Daling J.R., Doody D.R., Wipf G.C., Carter J.J., Madeleine M.M., Mao E.-J., et al. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J. Natl. Cancer Inst. 90:1998;1626-1636
53. Mork J., Lie A.K., Eystein G., Clark S., Hallmans G., Jellum E., et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N. Engl. J. Med. 344:2001;1125-1131
54. Smith E.M., Ritchie J.M., Summersgill K.F., Klussmann J.P., Lee J.H., Wang D., et al. Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int. J. Cancer. 108:2004;766-772
55. Lengauer C., Kinzler K.W., Vogelstein B. Genetic instabilities in human cancers. Nature. 396:1998;643-649
56. Hartwell L.H., Kastan M.B. Cell cycle control and cancer. Science. 266:1994;1821-1828
57. Sudbø J., Ried T., Bryne, Kildal W., Danielsen H.E., Reith A. Abnormal DNA content predicts the occurrence of carcinomas in non-dysplastic oral white patches. Oral Oncol. 37:2000;558-565
58. Sudbø J., Ried T., Bryne M., Kildal W., Danielsen H., Reith A. Abnormal DNA content predicts the occurrence of carcinomas in non-dysplastic oral white patches. Oral Oncol. 37:2001;558-565
59. Sudbø J., Kildal W., Risberg B., Koppang H.S., Danielsen H.E., Reith A. DNA content as a prognostic marker in patients with oral leukoplakia. N. Engl. J. Med. 344:2001;1270-1278
60. Sudbø J., Kildal W., Johannessen A.C., Koppang H.S., Sudbø A., Danielsen H.E., et al. Gross genomic aberrations in precancers: clinical implications of a long-term follow-up study in oral erythroplakias. J. Clin. Oncol. 20:2002;456-462
61. Scully C., Field J.K., Tanzawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma. 3: clinico-pathological applications. Oral Oncol. 36:2000;404-413
62. Scully C., Field J.K., Tanzawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma. 2: chromosomal aberrations. Oral Oncol. 36:2000;311-327
63. Scully C., Field J.K., Tanzawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle control. Oral Oncol. 36:2000;256-263